About this document
Eosinophilic Biomarkers in COPD Patients by Ameet Harishkumar is a document available to read on EtoBox.
This study investigates bronchodilator reversibility and eosinophilic biomarkers in chronic obstructive pulmonary disease (COPD) patients, finding that 32% of participants exhibited bronchodilator reversibility. Significant differences in eosinophilic biomarker levels were noted between reversible and non-reversible groups, with higher levels of sputum eosinophils and FeNO in reversible patients. The research highlights the importance of eosinophils in the inflammatory response of COPD patients, suggesting
- Author
- Ameet Harishkumar
- Language
- EN